Clinical Trials Browser

Phase 1 × Urologic Neoplasms × poly ICLC × Clear all

NCT03359239 2023-05-16

Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer

Phase 1 Completed

Urologic Neoplasms